Sodium-glucose cotransporter-2 inhibitor-associated euglycemic diabetic ketoacidosis in COVID-19-infected patients: A systematic review of case reports

BACKGROUND: Diabetic ketoacidosis (DKA) manifests as hyperglycemia, metabolic acidosis, and ketosis. However, euglycemic DKA (eu-DKA) conceals severe DKA with glucose levels below 200 mg/dL. Sodium-glucose cotransporter-2 (SGLT2) inhibitors can induce eu-DKA in diabetic patients. Notably, coronaviru...

Descripción completa

Detalles Bibliográficos
Autores principales: Khedr, Anwar, Hennawi, Hussam Al, Khan, Muhammed Khuzzaim, Eissa, Aalaa, Mir, Mikael, Rauf, Ibtisam, Nitesh, Jain, Surani, Salim, Khan, Syed Anjum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506011/
https://www.ncbi.nlm.nih.gov/pubmed/37727728
http://dx.doi.org/10.12998/wjcc.v11.i24.5700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506011/
https://www.ncbi.nlm.nih.gov/pubmed/37727728
http://dx.doi.org/10.12998/wjcc.v11.i24.5700

Ejemplares similares